...Luiz Henrique Corrêa Portari; Silvia Regina Correa-Silva; Julio Abucham Introduction: Cabergoline is the treatment of choice for prolactinomas. However, 10–20% of prolactinomas are resistant to cabergoline. Metformin, a biguanide widely used in the treatment of diabetes mellitus, has been shown...

...Shaojian Lin; Anke Zhang; Xun Zhang; Zhe Bao Wu Cabergoline is a dopamine agonist that has been used as the first-line treatment option for prolactin-secreting pituitary adenomas for several decades. It not only suppresses hormone production from these prolactinomas, but also causes tumour...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Hyperprolactinemia Pituitary tumor Dopamine agonists Bromocriptine Cabergoline Lisuride Pergolide Quinagolide Indications for therapy in patients...

... is frequently involved, which leads to visual damage, and patients occasionally suffer from ophthalmoplegia. Long-term (usually lifetime) therapy with high-dose dopamine agonists (cabergoline or bromocriptine), together with pituitary surgery in some cases and radiotherapy if required, can achieve biochemical...

... associated with an impaired metabolic profile. The current study aimed at investigating the effects of testosterone replacement and cabergoline (CAB) treatment on the metabolic profile in male hyperprolactinemic patients. Patients and Methods: Thirty-two men with prolactinomas, including 22 with total...

... in the pathogenesis of obesity and glucose intolerance and is reportedly associated with an impaired metabolic profile. The current study aimed at investigating the effects of 12- and 60-month treatment with cabergoline (CAB) on metabolic syndrome (MetS) in patients with prolactinomas. Patients and Methods: 61...

.... Later, drugs interfering with the physiological control of hormone secretion have been tested in vitro or in vivo. Dopamine (DA) agonists are one of these new potential treatments [ 2 ]. Dopamine agonists Cabergoline Cushing’s disease Adrenocorticotropic hormone Cortisol Adenoma Ectopic...

...% of patients not controlled by octreotide alone in short-term studies. This study was designed to evaluate short- and long-term efficacy of cabergoline in controlling IGF-I levels in acromegalic patients receiving octreotide. Design: Open-label, single arm, prospective trial. Nineteen patients (14 females, 29...

...Raquel S. Jallad; Marcello D. Bronstein Background: Previous data indicate a beneficial effect of cabergoline (CAB) association to somatostatin analogs (SA) in acromegalics resistant to SA monotherapy. Objective: To assess the efficacy of CAB association on acromegalics with high IGF-I on stable...

...Alexandru Saveanu; Ginette Gunz; Severine Guillen; Henry Dufour; Michael D. Culler; Philippe Jaquet Aim: We report the comparative efficacy of octreotide, cabergoline and multiple ligands directed towards the different somatostatin subtypes (ssts), such as BIM-23A779 and SOM-230, and of chimeric...